Translational Research
Volume 156, Issue 5 , Pages 282-291 , November 2010

Enteral diets enriched with medium-chain triglycerides and N-3 fatty acids prevent chemically induced experimental colitis in rats

Received 11 March 2010 ,Revised 21 July 2010 ,Accepted 22 July 2010.

References 

  1. Farraye FA, Odze RD, Eaden J, Itzkowitz SH. AGA technical review on the diagnosis and management of colorectal neoplasia in inflammatory bowel disease. Gastroenterology. 2010;138:746–774
  2. Larsen S, Bendtzen K, Nielsen OH. Extraintestinal manifestations of inflammatory bowel disease: epidemiology, diagnosis, and management. Ann Med. 2010;42:97–114
  3. Lichtenstein GR, Abreu MT, Cohen R, Tremaine W. American Gastroenterological Association Institute technical review on corticosteroids, immunomodulators, and infliximab in inflammatory bowel disease. Gastroenterology. 2006;130:940–987
  4. Shanahan F. Inflammatory bowel disease: immunodiagnostics, immunotherapeutics, and ecotherapeutics. Gastroenterology. 2001;120:622–635
  5. Razack R, Seidner DL. Nutrition in inflammatory bowel disease. Curr Opin Gastroenterol. 2007;23:400–405
  6. Lucendo AJ, De Rezende LC. Importance of nutrition in inflammatory bowel disease. World J Gastroenterol. 2009;15:2081–2088
  7. Jonkers D, Stockbrugger R. Review article: probiotics in gastrointestinal and liver diseases. Aliment Pharmacol Ther. 2007;26:133–148
  8. Guarner F. Prebiotics in inflammatory bowel diseases. Br J Nutr. 2007;98:S85–S89
  9. Kono H, Fujii H, Asakawa M, et al. Protective effects of medium-chain triglycerides on the liver and the gut in rats administered endotoxin. Ann Surg. 2003;237:246–255
  10. Kono H, Fujii H, Asakawa M, et al. Medium-chain triglycerides enhance secretory IgA expression in rat intestine after administration of endotoxin. Am J Physiol Gastrointest Liver Physiol. 2004;286:G1081–G1089
  11. Caradonna L, Amati L, Magrone T, Pellegrino NM, Jirillo E, Caccavo D. Enteric bacteria, lipopolysaccharides and related cytokines in inflammatory bowel disease: biological and clinical significance. J Endotoxin Res. 2000;6:205–214
  12. Kono H, Fujii H, Ishii K, Hosomura N, Ogiku M. Dietary medium-chain triglycerides prevent chemically induced experimental colitis in rats. Transl Res. 2010;155:131–141
  13. Sakurai T, Matsui T, Yao T, et al. Short-term efficacy of enteral nutrition in the treatment of active Crohn’s disease: a randomized, controlled trial comparing nutrient formulas. JPEN J Parenter Enteral Nutr. 2002;26:98–103
  14. Andoh A, Tsujikawa T, Ishizuka I, et al. N-3 fatty acid-rich diet prevents early response of interleukin-6 elevation in trinitrobenzene sulfonic acid-induced enteritis. Int J Mol Med. 2003;12:721–725
  15. Sou S, Sakurai T, Matsui T, et al. Short-term efficacy of a polymeric formula (RacolR) in the treatment of active Crohns disease. Nippon Daicho Komonbyo Gakkai Zasshi. 2008;61:509–515
  16. Morris GP, Beck PL, Herridge MS, Depew WT, Szewczuk MR, Wallace JL. Hapten-induced model of chronic inflammation and ulceration in the rat colon. Gastroenterology. 1989;96:795–803
  17. MacPherson BR, Pfeiffer CJ. Experimental production of diffuse colitis in rats. Digestion. 1978;17:135–150
  18. Krawisz JE, Sharon P, Stenson WF. Quantitative assay for acute intestinal inflammation based on myeloperoxidase activity. Assessment of inflammation in rat and hamster models. Gastroenterology. 1984;87:1344–1350
  19. Kono H, Wheeler MD, Rusyn I, et al. Gender differences in early alcohol-induced liver injury: role of CD14, NF-κB and TNF-α. Am J Physiol. 2000;278:G652–G661
  20. Rivera CA, Thurman RG. Tips for measuring endotoxin in plasma. Alcohol Clin Exp Res. 1998;22:2192–2194
  21. Sakamoto N, Kono S, Wakai K, et al. Dietary risk factors for inflammatory bowel disease: a multicenter case-control study in Japan. Inflamm Bowel Dis. 2005;11:154–163
  22. Shoda R, Matsueda K, Yamato S, Umeda N. Therapeutic efficacy of N-3 polyunsaturated fatty acid in experimental Crohn’s disease. J Gastroenterol. 1995;30:98–101
  23. Kono H, Enomoto N, Connor HD, et al. Medium-chain triglycerides inhibit free radical formation and TNF-alpha production in rats given enteral ethanol. Am J Physiol Gastrointest Liver Physiol. 2000;278:G467–G476
  24. Tsujikawa T, Ohta N, Nakamura T, et al. Medium-chain triglyceride-rich enteral nutrition is more effective than low-fat enteral nutrition in rat colitis, but is equal in enteritis. J Gastroenterol. 2001;36:673–680
  25. Taub DD. Chemokine-leukocyte interactions. The voodoo that they do so well. Cytokine Growth Factor Rev. 1996;7:355–376
  26. Becker C, Dornhoff H, Neufert C, et al. Cutting edge: IL-23 cross-regulates IL-12 production in T cell-dependent experimental colitis. J Immunol. 2006;177:2760–2764
  27. Garside P. Cytokines in experimental colitis. Clin Exp Immunol. 1999;118:337–339
  28. Neurath MF, Fuss I, Pasparakis M, et al. Predominant pathogenic role of tumor necrosis factor in experimental colitis in mice. Eur J Immunol. 1997;27:1743–1750
  29. Harada K, Toyonaga A, Mitsuyama K, Sasaki E, Tanikawa K. Role of cytokine-induced neutrophil chemoattractant, a member of the interleukin-8 family, in rat experimental colitis. Digestion. 1994;55:179–184
  30. Elson CO, Sartor RB, Tennyson GS, Riddell RH. Experimental models of inflammatory bowel disease. Gastroenterology. 1995;109:1344–1367
  31. Damas P, Ledoux D, Nys M, et al. Cytokine serum level during severe sepsis in human IL-6 as a marker of severity. Ann Surg. 1992;215:356–362
  32. Pritts T, Hungness E, Wang Q, Robb B, Hershko D, Hasselgren PO. Mucosal and enterocyte IL-6 production during sepsis and endotoxemia—role of transcription factors and regulation by the stress response. Am J Surg. 2002;183:372–383
  33. Molmenti EP, Ziambaras T, Perlmutter DH. Evidence for an acute phase response in human epithelial cells. J Biol Chem. 1993;268:14116–14126
  34. Wang Q, Fischer JE, Hasselgren PO. Treatment of endotoxemic mice with anti-interleukin-6 antibody paradoxically increases interleukin-6 levels and stimulates mucosal protein synthesis. Arch Surg. 1997;132:82–88
  35. Beagley KW, Eldridge JH, Lee F, et al. Interleukins and IgA synthesis. Human and murine interleukin 6 induce high rate IgA secretion in IgA-committed B cells. J Exp Med. 1989;169:2133–2148
  36. Grimble RF. Immunonutrition. Curr Opin Gastroenterol. 2005;21:216–222

PII: S1931-5244(10)00160-X

doi: 10.1016/j.trsl.2010.07.012

Translational Research
Volume 156, Issue 5 , Pages 282-291 , November 2010

Article Tools

* Image Usage & Resolution